Skip to the page

Data / Form D filings / STAGEZERO LIFE SCIENCES LTD.

STAGEZERO LIFE SCIENCES LTD.: Form D filings

STAGEZERO LIFE SCIENCES LTD., a biotechnology company in Richmond Hill, Ontario, Canada, filed 15 Form D notices with the SEC between 2009 and 2022. The latest, on March 17, 2022, reports $1.5 million sold of a $3.2 million offering to 1 investor.

Find out what STAGEZERO LIFE SCIENCES LTD. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
70 EAST BEAVER CREEK ROAD, UNIT 30, Richmond Hill, Ontario, Canada, L4B 3
Phone
(905) 209-2030
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Ontario, Canada
Revenue range
$5,000,001 - $25,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1454263

The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 17, 2022New notice$3,217,557$1,476,161$1,741,3961Mar 2, 2022sec.gov
Feb 7, 2022Amendment$7,399,579$3,288,702$4,110,8776Nov 26, 2021sec.gov
Jan 4, 2022New notice$7,399,579$3,288,702$4,110,8776Nov 26, 2021sec.gov
Dec 18, 2020New notice$338,143$198,309$139,8341Dec 4, 2020sec.gov
Jun 23, 2020New notice$113,448$113,371$771Feb 19, 2020sec.gov
Jun 22, 2018New notice$2,543,212$1,541,783$1,001,4291Jun 7, 2018sec.gov
Jun 6, 2018New notice$1,581,103$852,219$728,8843May 22, 2018sec.gov
Jul 31, 2017New notice$245,558$245,558$03Jul 14, 2017sec.gov
Apr 14, 2016New noticeIndefinite$370,435Indefinite3Mar 31, 2016sec.gov
Jul 22, 2014New notice$7,210,000$5,971,000$1,239,0008Jul 7, 2014sec.gov
Dec 28, 2012New notice$6,303,211$6,303,211$014Dec 14, 2012sec.gov
Jun 23, 2011New notice$5,273,385$5,273,385$011Jun 9, 2011sec.gov
Nov 26, 2010New notice$1,354,526$1,354,526$07Nov 12, 2010sec.gov
Dec 31, 2009New notice$100,808$100,808$02Dec 21, 2009sec.gov
Jul 23, 2009New notice$172,080$172,080$01Jul 9, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Harry R. GlorikianDirector
Garth R. MacRaeDirector
Rory Janice RiggsDirector
Richard Janice HustonDirector
James R. Howard-TrippExecutive Officer, Director

Every Form D from the week of Mar 14, 2022 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what STAGEZERO LIFE SCIENCES LTD. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.